SCHEMBL8963541

SCHEMBL8963541

Cc1ccccc1-c1nc(CN2CCN(C(c3ccccc3)c3ccccc3)CC2)c(C)[nH]1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.49
DRD4 P21917 2/20 0.49
DRD3 P35462 2/20 0.49
MAPT P10636 2/20 0.45
CYP3A4 P08684 3/20 0.44
CYP2C19 P33261 2/20 0.44
CYP2C9 P11712 1/20 0.44
ADORA3 P0DMS8 2/20 0.44
CNR1 P21554 2/20 0.44
HRH1 P35367 2/20 0.44
OPRK1 P41145 2/20 0.44
KCNH2 Q12809 2/20 0.44
GHSR Q92847 2/20 0.44
USP2 O75604 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
HPN P05981 1/20 0.44
CHRM2 P08172 1/20 0.44
ADRA2A P08913 1/20 0.44
CHRM1 P11229 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8963948 0.89 DRD3 (0.47) DRD2DRD4DRD3MAPTCYP3A4
SCHEMBL8964105 0.88 P2RX7 (0.43) DRD2DRD3MAPTCYP3A4CYP2C19
SCHEMBL8963668 0.87 DRD2 (0.64) DRD2DRD4DRD3MAPTCYP3A4
SCHEMBL8969984 0.87 LMNA (0.47) DRD2DRD4DRD3MAPTCYP3A4
SCHEMBL8963754 0.87 MAPT (0.53) DRD2DRD4DRD3MAPTCYP3A4
Lifarizine SCHEMBL676318 0.84 DRD2 (0.57) DRD2DRD4DRD3MAPTCYP3A4
SCHEMBL8963644 0.83 DRD3 (0.56) DRD2DRD4DRD3CYP3A4CYP2C19
Lifarizine SCHEMBL8963776 0.83 DRD2 (0.56) DRD2DRD4DRD3MAPTCYP3A4
SCHEMBL8963684 0.83 CYP3A4 (0.49) DRD2DRD4DRD3MAPTCYP3A4
SCHEMBL8963843 0.81 CYP3A4 (0.54) DRD2DRD4DRD3MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5514800-A CALCIUM CHANNEL BLOCKERS, CEREBRAL ISCHEMIA SYNTEX PHARMACEUTICALS, LTD. (GB) 1996-05-07 US disclosed
US-5276034-A Cardiovascular disorders, nervous system disorders, diuretics, antiischemic agents or antispasmodic agents SYNTEX PHARMACEUTICAL LTD. (GB) 1994-01-04 US disclosed
US-5252736-A Calcium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1993-10-12 US disclosed
EP-0289227-B1 SUBSTITUTED IMIDAZOLYL-ALKYL-PIPERAZINE AND -DIAZEPINE DERIVATIVES SYNTEX PHARMACEUTICALS LTD. (GB) 1992-04-08 EP disclosed
US-5091428-A Calcium channel blockers preferential for cerebral blood vessels SYNTEX PHARMACEUTICALS, LTD. (BM) 1992-02-25 US disclosed
US-5043447-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1991-08-27 US disclosed
US-5010075-A Antiepilepic, hypotensive, antiarrhythmia, antiischemic agent SYNTEX PHARMACEUTICALS LTD. (GB) 1991-04-23 US disclosed
US-4935417-A CALCIUM CHANNEL BLOCKERS SYNTEX PHARMACEUTICALS LTD. (BM) 1990-06-19 US disclosed
US-4829065-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1989-05-09 US disclosed
EP-0289227-A1 Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS LTD. (GB) 1988-11-02 EP disclosed